Search

Search Results

1. Cardiovascular Outcomes Research A Clinician’s Guide to Cardiovascular Epidemiology and Clinical Outcomes Trials

   This book provides clinicians with the information needed to effectively interpret the literature from observational and interventional...

   Kevin C. Maki, Don P. Wilson in Contemporary Cardiology

   Book 2024
   

2. White Coat Hypertension & Cardiovascular Outcomes

   Purpose of Review

   This review aims to inform the reader of the complexity of blood pressure responses when comparing blood pressure measured in the...

   Raymond R. Townsend, Jordana B. Cohen in Current Hypertension Reports

   Article Open access 18 May 2024
   

3. CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

   The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November...

   Oliver Schnell, Katharine Barnard-Kelly, ... Eberhard Standl in Cardiovascular Diabetology

   Article Open access 19 March 2024

4. Transgender healthcare: metabolic outcomes and cardiovascular risk

   Transgender identity is often associated with gender dysphoria and minority stress. Gender-affirming hormone treatment (GAHT) includes masculinising...

   Dorte Glintborg, Louise L. Christensen, Marianne S. Andersen in Diabetologia

   Article 03 July 2024
   

5. Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study

   Background/Objective

   There are limited real-world studies assessing semaglutide weight loss and associated comorbidity and metabolic outcomes over...

   Wissam Ghusn, Sima Fansa, ... Andres Acosta in International Journal of Obesity

   Article 01 February 2024
   

6. PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes

   Proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) plays a crucial role in the modulation of lipid metabolism as a critical negative regulator of...

   Daniela Grejtakova, Iveta Boronova, ... Stefano Bellosta in Cardiovascular Drugs and Therapy

   Article Open access 22 June 2024
   

7. Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study

   Background

   Although recent guidelines advocate for HbA1c target individualization, a comprehensive criterion for patient categorization remains...

   Junyu Pei, **aopu Wang, ... **nqun Hu in Cardiovascular Diabetology

   Article Open access 27 October 2023
   

8. Cardiovascular outcomes between COVID-19 and non-COVID-19 pneumonia: a nationwide cohort study

   Background

   Previous studies that assessed the risk of cardiovascular outcomes in survivors of coronavirus disease 2019 (COVID-19) were likely limited...

   Min-Taek Lee, Moon Seong Baek, ... Won-Young Kim in BMC Medicine

   Article Open access 20 October 2023
   

9. CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

   The 8th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Kidney, and Glycemic Outcomes was held virtually on November 10–12, 2022....

   Oliver Schnell, Tadej Battelino, ... Eberhard Standl in Cardiovascular Diabetology

   Article Open access 16 March 2023

10. Preventing Adverse Cardiovascular Outcomes in Pregnancy Complicated by Obesity

    Purpose of Review

    Obesity is a chronic disease that is becoming increasingly prevalent, and more individuals of reproductive age have obesity prior to...

    Aarti M Purohit, Chigolum Pamela Oyeka, ... Garima Sharma in Current Obstetrics and Gynecology Reports

    Article 06 April 2023
    

11. Cardiovascular and bone health outcomes in older people with subclinical hypothyroidism treated with levothyroxine: a systematic review and meta-analysis

    Background

    Thyroid dysfunction is common in older people, with females at higher risk. Evidence suggests that thyroid-stimulating hormone (TSH) levels...

    Mia Holley, Salman Razvi, ... Scott Wilkes in Systematic Reviews

    Article Open access 08 May 2024
    

12. Cardiovascular screening outcomes in the Dutch survivorship care program for Hodgkin lymphoma survivors

    Purpose

    Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular disease (CVD) due to former lymphoma treatment. In 2013,...

    Eline M. J. Lammers, Annelies Nijdam, ... Berthe M. P. Aleman in Journal of Cancer Survivorship

    Article 23 April 2024
    

13. Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study

    Background

    Sodium-glucose co-transporter-2 inhibitors displayed cardiovascular benefits in type 2 diabetes mellitus in previous studies; however,...

    Jaehyun Lim, You-Jung Choi, ... Hyung-Kwan Kim in Cardiovascular Diabetology

    Article Open access 26 July 2023
    

14. Urinary catecholamine excretion, cardiovascular variability, and outcomes in tetanus

    Severe tetanus is characterized by muscle spasm and cardiovascular system disturbance. The pathophysiology of muscle spasm is relatively well...

    Duc Hong Du, Nguyen Quan Nhu Hao, ... C. Louise Thwaites in Tropical Medicine and Health

    Article Open access 30 March 2023
    

15. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome

    Background

    Insulin resistance (IR) is linked to both the complexity of coronary artery lesions and the prognosis of acute coronary syndrome (ACS)....

    Qiang Chen, Shiqiang **ong, ... **gang Zheng in Cardiovascular Diabetology

    Article Open access 16 May 2024
    

16. Associations of obesity indices change with cardiovascular outcomes: a dose-response meta-analysis

    Background

    Little is known about the degrees and shapes of associations of changes in obesity indices with cardiovascular disease (CVD) and mortality...

    Lyu Wang, Hanyue Ding, ... Martin C. S. Wong in International Journal of Obesity

    Article 09 February 2024
    

17. Risk of Adverse Cardiovascular Outcomes in Postmenopausal Women with Inflammatory Bowel Disease

    Background

    Individuals with inflammatory bowel disease (IBD) who lack traditional cardiovascular disease (CVD) risk factors, such as young females,...

    Ruby Greywoode, Joseph Larson, ... Sylvia Wassertheil-Smoller in Digestive Diseases and Sciences

    Article Open access 29 April 2024
    

18. Resting heart rate and cardiovascular outcomes in patients with non-paroxysmal atrial fibrillation: CODE-AF registry

    Background

    The prognostic significance of resting heart rate and its therapeutic target in atrial fibrillation (AF) is uncertain. We sought to...

    Han** Park, Hee Tae Yu, ... Boyoung Joung in International Journal of Arrhythmia

    Article Open access 01 July 2023
    

19. Long-term cardiovascular outcomes of gestational diabetes mellitus: a prospective UK Biobank study

    Background

    Previous studies showed that gestational diabetes mellitus (GDM) can be a risk factor for subsequent atherosclerotic cardiovascular...

    Seung Mi Lee, Manu Shivakumar, ... Jae-Seung Yun in Cardiovascular Diabetology

    Article Open access 29 October 2022
    

20. Cardiovascular Comorbidities Do Not Impact Prostate Artery Embolisation (PAE) Outcomes: Retrospective Analysis of the National UK-ROPE Registry

    Purpose

    Prostate artery embolisation (PAE) is a key treatment for the management of symptomatic benign prostatic hyperplasia (BPH). Common...

    Ganesh Vigneswaran, Drew Maclean, ... Sachin Modi in CardioVascular and Interventional Radiology

    Article Open access 27 November 2023